SENTINEL U APS WOMEN'S HEALTH GYN,
TANISHA SMITH 100% SCORE, ACTIVITY
REPORT LATEST 2026-2027 UPDATE
49 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Apply current ACOG/CDC guidelines to complex gynecologic scenarios
2 Analyze diagnostic data to differentiate gynecologic pathologies
3 Formulate safe, patient-centered pharmacologic and non-pharmacologic management plans
4 Sentinel U APS Women's Health GYN
5 Tanisha Smith 100% Score
6 Activity Report Latest 2026
7 2027 Update
8 Foundations of Women's Health - Gynecology (Sentinel U Advanced Practice Simulation)
9 Applied Women's Health - Gynecology (Sentinel U Advanced Practice Simulation)
10 Advanced Women's Health - Gynecology (Sentinel U Advanced Practice Simulation)
11 Women's Health - Gynecology (Sentinel U Advanced Practice Simulation) Review
ABSTRACT
This study document brings together 49 carefully worded exam questions drawn from Sentinel U
APS Women's Health GYN, Tanisha Smith 100% Score, Activity Report Latest 2026-2027 Update,
with the strongest emphasis placed on Apply current ACOG/CDC guidelines to complex
gynecologic scenarios, Analyze diagnostic data to differentiate gynecologic pathologies, Formulate
safe and patient-centered pharmacologic and non-pharmacologic management plans. Every item
follows the wording style and level of reasoning you meet in the real paper, and each one is paired
with a clear rationale so the correct choice is never a guess. Work through the set at your own
pace, mark the questions that slow you down, then come back to them until the reasoning feels
automatic. Learners who revise this way walk into the exam room recognising the pattern behind
the questions instead of meeting them for the first time. Keep going - steady, honest practice is
what turns a difficult paper into a comfortable pass.
Page 1
,Q1 APPLY CURRENT ACOG/CDC GUIDELINES TO COMPLEX GYNECOLOGIC SCENARIOS
A 52-year-old woman presents with 8 months of amenorrhea, severe vasomotor
symptoms, and a history of breast cancer treated with tamoxifen. Which of the
following is the most appropriate first-line pharmacologic therapy for her
vasomotor symptoms?
A. Conjugated equine estrogen 0.625 mg daily
B. Paroxetine 7.5 mg daily
C. Venlafaxine XR 75 mg daily CORRECT
D. Gabapentin 300 mg three times daily
RATIONALE: Venlafaxine is a first-line non-hormonal option for vasomotor symptoms in breast
cancer survivors and is preferred over paroxetine due to CYP2D6 inhibition affecting tamoxifen
efficacy. Estrogen is contraindicated post-breast cancer, and gabapentin is second-line with less
efficacy.
Q2 APPLY CURRENT ACOG/CDC GUIDELINES TO COMPLEX GYNECOLOGIC SCENARIOS
A 28-year-old woman reports a 3-day history of dysuria, purulent cervical
discharge, and lower abdominal pain. NAAT testing is positive for Chlamydia
trachomatis and Neisseria gonorrhoeae. She has a severe penicillin allergy. Which
treatment regimen is most appropriate per CDC 2021 guidelines?
A. Ceftriaxone 500 mg IM single dose plus doxycycline 100 mg BID x 7 days
B. Azithromycin 1 g PO single dose plus doxycycline 100 mg BID x 7 days
C. Cefixime 800 mg PO single dose plus azithromycin 1 g PO single dose
D. Gentamicin 240 mg IM single dose plus azithromycin 2 g PO single dose CORRECT
RATIONALE: For severe penicillin allergy, CDC recommends gentamicin 240 mg IM plus
azithromycin 2 g PO as an alternative for gonorrhea. Ceftriaxone and cefixime are
contraindicated due to cross-reactivity risk; azithromycin monotherapy is no longer recommended
due to resistance.
Page 2
, Q3 APPLY CURRENT ACOG/CDC GUIDELINES TO COMPLEX GYNECOLOGIC SCENARIOS
A 45-year-old woman with heavy menstrual bleeding has a PALM-COEIN
evaluation. Her ultrasound shows a 3 cm submucosal fibroid. Which of the
following is the most definitive and fertility-sparing treatment option?
A. Levonorgestrel-releasing intrauterine system (LNG-IUS)
B. Hysteroscopic myomectomy CORRECT
C. Uterine artery embolization
D. Tranexamic acid 1300 mg TID during menses
RATIONALE: Hysteroscopic myomectomy is the definitive, fertility-sparing surgical treatment for
submucosal fibroids. LNG-IUS and tranexamic acid reduce bleeding but do not treat the fibroid;
uterine artery embolization is not first-line for fertility preservation.
Q4 APPLY CURRENT ACOG/CDC GUIDELINES TO COMPLEX GYNECOLOGIC SCENARIOS
A 60-year-old postmenopausal woman presents with vulvar pruritus and a 2 cm
ulcerated lesion on the labia majora. Biopsy reveals squamous cell carcinoma.
Which of the following is the most important prognostic factor for survival?
A. Tumor size
B. Inguinal lymph node status CORRECT
C. Depth of invasion
D. HPV status
RATIONALE: Inguinal lymph node status is the strongest prognostic factor for vulvar squamous
cell carcinoma survival. Tumor size and depth of invasion are important but less predictive than
nodal involvement; HPV status is associated with better prognosis but is not the most critical
factor.
Page 3
TANISHA SMITH 100% SCORE, ACTIVITY
REPORT LATEST 2026-2027 UPDATE
49 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Apply current ACOG/CDC guidelines to complex gynecologic scenarios
2 Analyze diagnostic data to differentiate gynecologic pathologies
3 Formulate safe, patient-centered pharmacologic and non-pharmacologic management plans
4 Sentinel U APS Women's Health GYN
5 Tanisha Smith 100% Score
6 Activity Report Latest 2026
7 2027 Update
8 Foundations of Women's Health - Gynecology (Sentinel U Advanced Practice Simulation)
9 Applied Women's Health - Gynecology (Sentinel U Advanced Practice Simulation)
10 Advanced Women's Health - Gynecology (Sentinel U Advanced Practice Simulation)
11 Women's Health - Gynecology (Sentinel U Advanced Practice Simulation) Review
ABSTRACT
This study document brings together 49 carefully worded exam questions drawn from Sentinel U
APS Women's Health GYN, Tanisha Smith 100% Score, Activity Report Latest 2026-2027 Update,
with the strongest emphasis placed on Apply current ACOG/CDC guidelines to complex
gynecologic scenarios, Analyze diagnostic data to differentiate gynecologic pathologies, Formulate
safe and patient-centered pharmacologic and non-pharmacologic management plans. Every item
follows the wording style and level of reasoning you meet in the real paper, and each one is paired
with a clear rationale so the correct choice is never a guess. Work through the set at your own
pace, mark the questions that slow you down, then come back to them until the reasoning feels
automatic. Learners who revise this way walk into the exam room recognising the pattern behind
the questions instead of meeting them for the first time. Keep going - steady, honest practice is
what turns a difficult paper into a comfortable pass.
Page 1
,Q1 APPLY CURRENT ACOG/CDC GUIDELINES TO COMPLEX GYNECOLOGIC SCENARIOS
A 52-year-old woman presents with 8 months of amenorrhea, severe vasomotor
symptoms, and a history of breast cancer treated with tamoxifen. Which of the
following is the most appropriate first-line pharmacologic therapy for her
vasomotor symptoms?
A. Conjugated equine estrogen 0.625 mg daily
B. Paroxetine 7.5 mg daily
C. Venlafaxine XR 75 mg daily CORRECT
D. Gabapentin 300 mg three times daily
RATIONALE: Venlafaxine is a first-line non-hormonal option for vasomotor symptoms in breast
cancer survivors and is preferred over paroxetine due to CYP2D6 inhibition affecting tamoxifen
efficacy. Estrogen is contraindicated post-breast cancer, and gabapentin is second-line with less
efficacy.
Q2 APPLY CURRENT ACOG/CDC GUIDELINES TO COMPLEX GYNECOLOGIC SCENARIOS
A 28-year-old woman reports a 3-day history of dysuria, purulent cervical
discharge, and lower abdominal pain. NAAT testing is positive for Chlamydia
trachomatis and Neisseria gonorrhoeae. She has a severe penicillin allergy. Which
treatment regimen is most appropriate per CDC 2021 guidelines?
A. Ceftriaxone 500 mg IM single dose plus doxycycline 100 mg BID x 7 days
B. Azithromycin 1 g PO single dose plus doxycycline 100 mg BID x 7 days
C. Cefixime 800 mg PO single dose plus azithromycin 1 g PO single dose
D. Gentamicin 240 mg IM single dose plus azithromycin 2 g PO single dose CORRECT
RATIONALE: For severe penicillin allergy, CDC recommends gentamicin 240 mg IM plus
azithromycin 2 g PO as an alternative for gonorrhea. Ceftriaxone and cefixime are
contraindicated due to cross-reactivity risk; azithromycin monotherapy is no longer recommended
due to resistance.
Page 2
, Q3 APPLY CURRENT ACOG/CDC GUIDELINES TO COMPLEX GYNECOLOGIC SCENARIOS
A 45-year-old woman with heavy menstrual bleeding has a PALM-COEIN
evaluation. Her ultrasound shows a 3 cm submucosal fibroid. Which of the
following is the most definitive and fertility-sparing treatment option?
A. Levonorgestrel-releasing intrauterine system (LNG-IUS)
B. Hysteroscopic myomectomy CORRECT
C. Uterine artery embolization
D. Tranexamic acid 1300 mg TID during menses
RATIONALE: Hysteroscopic myomectomy is the definitive, fertility-sparing surgical treatment for
submucosal fibroids. LNG-IUS and tranexamic acid reduce bleeding but do not treat the fibroid;
uterine artery embolization is not first-line for fertility preservation.
Q4 APPLY CURRENT ACOG/CDC GUIDELINES TO COMPLEX GYNECOLOGIC SCENARIOS
A 60-year-old postmenopausal woman presents with vulvar pruritus and a 2 cm
ulcerated lesion on the labia majora. Biopsy reveals squamous cell carcinoma.
Which of the following is the most important prognostic factor for survival?
A. Tumor size
B. Inguinal lymph node status CORRECT
C. Depth of invasion
D. HPV status
RATIONALE: Inguinal lymph node status is the strongest prognostic factor for vulvar squamous
cell carcinoma survival. Tumor size and depth of invasion are important but less predictive than
nodal involvement; HPV status is associated with better prognosis but is not the most critical
factor.
Page 3
